✦ LIBER ✦

Recombinant enzyme replacement therapy for infantile-onset Pompe disease

✍ Scribed by Michio Hirano

Book ID: 107545571
Publisher: Springer
Year: 2008
Tongue: English
Weight: 96 KB
Volume: 8
Category: Article
ISSN: 1528-4042
DOI: 10.1007/s11910-008-0008-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enzyme Replacement Therapy for Pompe Dis

Enzyme Replacement Therapy for Pompe Disease

✍ Corrado Angelini; Claudio Semplicini 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 297 KB

Enzyme replacement therapy induces T-cel

Enzyme replacement therapy induces T-cell responses in late-onset Pompe disease

✍ Miklos Banati; Zsolt Hosszu; Anita Trauninger; Laszlo Szereday; Zsolt Illes 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

## Abstract ## Introduction: Enzyme replacement therapy (ERT) in ultra‐orphan Pompe disease generates anti‐rhGAA antibodies, which may interfere with efficacy. ## Methods: rhGAA‐specific T‐cell responses were examined at different time‐points in 6 Hungarian patients treated with rhGAA and compar

Enzyme replacement therapy in late-onset

Enzyme replacement therapy in late-onset Pompe's disease: A three-year follow-up

✍ Léon P. F. Winkel; Johanna M. P. Van den Hout; Joep H. J. Kamphoven; Janus A. M. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

Morphological changes in muscle tissue o

Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy

✍ Léon P. F. Winkel; Joep H. J. Kamphoven; Hannerieke J. M. P. Van Den Hout; Lies 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

## Abstract Pompe's disease (glycogen storage disease type II) is an autosomal recessive myopathy caused by lysosomal α‐glucosidase deficiency. Enzyme replacement therapy (ERT) is currently under development for this disease. We evaluated the morphological changes in muscle tissue of four children

Use of the muscle volume analyzer to eva

Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease

✍ Fuminobu Sugai; Yosuke Kokunai; Yoichi Yamamoto; Goichi Hashida; Kengo Shimazu; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 260 KB

Enzyme therapy for Pompe disease with re

Enzyme therapy for Pompe disease with recombinant human α-glucosidase from rabbit milk

✍ J.M.P. Van den Hout; A.J.J. Reuser; J.B.C. de Klerk; W.F. Arts; J.A.M. Smeitink; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 116 KB